课题基金 / 基金详情

Epigenetic mechanisms regulating pluripotency from embryonic to adult neurogeneisis

Epigenetic mechanisms regulating pluripotency from embryonic to adult neurogeneisis
从胚胎到成人神经发生调节多能性的表观遗传机制
批准号:
MR/M010554/1
负责人:
Francis Szele
金额:
$48.73万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

Francis Szele的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neurological diseases are amongst the most devastating since the brain does a very poor job in healing itself. In the large majority of cases, new nerve cells cannot be produced to replace injured tissue. With the increase in the population's average age, diseases such as Alzheimer's, Parkinson's and stroke will take an increasingly burdensome toll on individuals, families and society. Hope for a therapeutic solution has arisen with the discovery of brain stem cells and increased understanding of how they are controlled. Stem cells are found in two specific regions of the brain and continue to generate nerve cells in those restricted areas. Our goal is to understand how to enhance this process and entice it to be of more general relevance throughout the brain. In the past decade, laboratories around the world including ours (Shen in Beijing, Szele in Oxford) have discovered many molecules that stimulate stem cells to grow during normal development and molecules that stimulate them to repair a damaged brain. Use of this knowledge will allow us to develop medicines that mimic these molecules and thereby stimulate the growth of stem cells for brain repair. Since the repair of the adult brain is conceptually similar to the development of the brain, we also seek to understand fundamental molecular mechanisms regulating the generation of nerve cells from human embryonic stem cells (hESC). Amazingly, hESC can be grown in cell culture dishes, allowing us to discover molecules that increase nerve cell production. Similarly, adult brain stem cells can be grown in cell culture to study their generation of nerve cells. In this grant, we will use and compare both approaches in our goal to increase stem cell-derived nerve cell generation.Most research in the 20th century has uncovered how individual molecules regulate stem cells one at a time. In this century, a shift in emphasis has occurred, and the field is now seeking to understand how molecules work together to coordinate stem cell nerve generation. This is an intelligent shift since dozens to hundreds of molecules usually are required to coordinate stem cell nerve generation. But how are so many molecules regulated in the same space and at the same time in such a coordinated way? The answer is in a fashion analogous to how a conductor organizes an orchestra: she may increase the loudness of the string section whilst repressing the horns. So-called "epigenetic" mechanisms coordinate dozens to hundreds of molecules by causing some to be emphasized and some to be repressed. Epigenetic mechanisms can turn molecules completely on or off, or they can more subtly turn them up or down. Importantly, they do this in stem cells and thereby cause the cells to either proliferate or to turn into nerve cells.In our laboratories, we study how epigenetic mechanisms increase nerve cell production from embryonic stem cells (Shen, Beijing) and from adult brain stem cells (Szele, Oxford). In this collaborative project, we will seek to understand the extent to which the same molecules govern nerve cell production in the embryo as we as in the adult. We will also use this novel molecular knowledge to increase stem cell-mediated nerve cell production in a model of stroke. Brains of infants have a far higher plasticity than those in the adult and aged population. However, even infant brains do not completely repair themselves in diseases such as cerebral palsy. Thus, we will also seek to understand how epigenetic molecules enhance stem cell-mediated repair of a model of infant cerebral palsy.Our overarching goal is to eventually use this information to increase nerve cell production from stem cells. This exciting branch of regenerative medicine is one of the best hopes for the future of treating neurological disorders.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Traumatic Brain Injury Activation of the Adult Subventricular Zone Neurogenic Niche.
成人室内神经源性小众的创伤性脑损伤激活。
DOI: 10.3389/fnins.2016.00332
发表时间: 2016
期刊: Frontiers in neuroscience
影响因子: 4.3
作者: [Chang EH, Adorjan I, Mundim MV, Sun B, Dizon ML, Szele FG]
通讯作者: Szele FG
Driven impurity in an ultracold one-dimensional Bose gas with intermediate interaction strength
具有中等相互作用强度的超冷一维玻色气体中的驱动杂质
DOI: 10.1103/physreva.93.013613
发表时间: 2016
期刊: Physical Review A
影响因子: 2.9
作者: [Castelnovo C]
通讯作者: Castelnovo C
DOI: 10.1093/cercor/bhx289
发表时间: 2018-04-01
期刊: Cerebral cortex (New York, N.Y. : 1991)
影响因子: --
作者: [Sun B, Chang E, Gerhartl A, Szele FG]
通讯作者: Szele FG
DOI: 10.1038/s41598-017-06358-x
发表时间: 2017-08-01
期刊: Scientific reports
影响因子: 4.6
作者: [Graham AD, Olof SN, Burke MJ, Armstrong JPK, Mikhailova EA, Nicholson JG, Box SJ, Szele FG, Perriman AW, Bayley H]
通讯作者: Bayley H
Molecular mechanisms regulating subventricular zone progenitor migration
  • 批准号:
    BB/J018635/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $51.77万
  • 财政年份:
    2013
  • 负责人:
    Francis Szele
  • 依托单位:
Polycomb repressive complex 2 regulation of neurogenesis
  • 批准号:
    MR/K008927/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $4.91万
  • 财政年份:
    2012
  • 负责人:
    Francis Szele
  • 依托单位:
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: